Genetic polymorphisms modifying oxidative stress are associated with disease activity in rheumatoid arthritis patients

Disease Markers

Volumn 26, Issue 1, 2009, Pages 41-48

  Bohanec Grabar, Petra ^a   Logar, Duššan ^b   Tomšič, Matija ^b   Rozman, Blaž ^b   Dolžan, Vita ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Disease activity; Genetic polymorphism; Reactive oxygen species; Rheumatoid arthritis

Indexed keywords

ALANINE; CATALASE; CHLOROQUINE; CYCLOSPORIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLYCINE; INDUCIBLE NITRIC OXIDE SYNTHASE; LEFLUNOMIDE; MANGANESE SUPEROXIDE DISMUTASE; METHOTREXATE; REACTIVE OXYGEN METABOLITE; SALAZOSULFAPYRIDINE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; VALINE;

ADULT; ALLELE; ARTICLE; CORTICOSTEROID THERAPY; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GOLD THERAPY; HETEROZYGOTE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OXIDATIVE STRESS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 61349109319     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.3233/DMA-2009-0603     Document Type: Article

References (39)

1. M. Feldmann, F.M. Brennan and R.N. Maini, Role of cytokines in rheumatoid arthritis, Annu Rev Immunol 14 (1996), 397-440.
2. J.B. Weinberg, Nitric oxide production and nitric oxide synthase type 2 expression by human mononuclear phagocytes: a review, Mol Med 4 (1998), 557-591.
3. C.H. Woo, T.H. Kim, J.A. Choi, H.C. Ryu, J.E. Lee, H.J. You, Y.S. Bae and J.H. Kim, Inhibition of receptor internalization attenuates the TNFalpha-induced ROS generation in nonphagocytic cells, Biochem Biophys Res Commun 351 (2006), 972-978.
4. B. Halliwell, Oxygen radicals, nitric oxide and human inflammatory joint disease, Ann Rheum Dis 54 (1995), 505-510.
5. C.A. Hitchon and H.S. El-Gabalawy, Oxidation in rheumatoid arthritis, Arthritis Res Ther 6 (2004), 265-278.
6. S. Shimoda-Matsubayashi, H. Matsumine, T. Kobayashi, Y. Nakagawa-Hattori, Y. Shimizu and Y. Mizuno, Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's disease, Biochem Biophys Res Commun 226 (1996), 561-565.
7. R.J. Folz, L. Peno-Green and J.D. Crapo, Identification of a homozygous missense mutation (Arg to Gly) in the critical binding region of the human EC-SOD gene (SOD3) and its association with dramatically increased serum enzyme levels, Hum Mol Genet 3 (1994), 2251-2254.
8. L. Forsberg, L. Lyrenas, U. de Faire and R. Morgenstern, A common functional C-T substitution polymorphism in the promoter region of the human catalase gene influences transcription factor binding, reporter gene transcription and is correlated to blood catalase levels, Free Radic Biol Med 30 (2001), 500-505.
9. A.G.Wilson, F.S. di Giovine, A.I. Blakemore and G.W. Duff, Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product, Hum Mol Genet 1 (1992), 353.
10. S.M. Herrmann, S. Ricard, V. Nicaud, C. Mallet, D. Arveiler, A. Evans, J.B. Ruidavets, G. Luc, L. Bara, H.J. Parra, O. Poirier and F. Cambien, Polymorphisms of the tumour necrosis factor-alpha gene, coronary heart disease and obesity, Eur J Clin Invest 28 (1998), 59-66.
11. K.M. Warpeha, W. Xu, L. Liu, I.G. Charles, C.C. Patterson, F. Ah-Fat, S. Harding, P.M. Hart, U. Chakravarthy and A.E. Hughes, Genotyping and functional analysis of a polymorphic (CCTTT)(n) repeat of NOS2A in diabetic retinopathy, Faseb J 13 (1999), 1825-1832.
12. F.C. Arnett, S.M. Edworthy, D.A. Bloch, D.J. McShane, J.F. Fries, N.S. Cooper, L.A. Healey, S.R. Kaplan, M.H. Liang, H.S. Luthra and e. al, The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis, Arthritis Rheum 31 (1988), 315-324.
13. M.L. Prevoo, M.A. van 't Hof, H.H. Kuper, M.A. van Leeuwen, L.B. van de Putte and P.L. van Riel, Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis, Arthritis Rheum 38 (1995), 44-48.
14. S.A. Miller, D.D. Dykes and H.F. Polesky, A simple salting out procedure for extracting DNA from human nucleated cells, Nucleic Acids Res 16 (1988), 1215.
15. W. Xu, L. Liu, P.C. Emson, C.R. Harrington and I.G. Charles, Evolution of a homopurine-homopyrimidine pentanucleotide repeat sequence upstream of the human inducible nitric oxide synthase gene, Gene 204 (1997), 165-170.
16. L. Excoffier, G. Laval and S. Schneider, Arlequin ver. 3.0: An integrated software package for population genetics data analysis, Evolutionary Bioinformatics Online 1 (2005), 47-50.
17. E. Erdfelder, F. Faul and A. Buchner, GPOWER: A general power analysis program, Behavior Research Methods, Instruments, & Computers 28 (1996), 1-11.
18. J. Ahn, S. Nowell, S.E. McCann, J. Yu, L. Carter, N.P. Lang, F.F. Kadlubar, L.D. Ratnasinghe and C.B. Ambrosone, Associations between catalase phenotype and genotype: modification by epidemiologic factors, Cancer Epidemiol Biomarkers Prev 15 (2006), 1217-1222.
19. M. Bastaki, K. Huen, P. Manzanillo, N. Chande, C. Chen, J.R. Balmes, I.B. Tager and N. Holland, Genotype-activity relationship for Mn-superoxide dismutase, glutathione peroxidase 1 and catalase in humans, Pharmacogenet Genomics 16 (2006), 279-286.
20. A. El-Sohemy, M.C. Cornelis, Y.W. Park and S.C. Bae, Catalase and PPARgamma2 genotype and risk of rheumatoid arthritis in Koreans, Rheumatol Int 26 (2006), 388-392.
21. D.L. Mattey, A.B. Hassell, P.T. Dawes, P.W. Jones, L. Yengi, J. Alldersea, R.C. Strange and A.A. Fryer, Influence of polymorphism in the manganese superoxide dismutase locus on disease outcome in rheumatoid arthritis: evidence for interaction with glutathione S-transferase genes, Arthritis Rheum 43 (2000), 859-864.
22. J.H. Yen, C.J. Chen, W.C. Tsai, C.H. Lin, T.T. Ou, C.J. Hu and H.W. Liu, Manganese superoxide dismutase and cytochrome P450 1A1 genes polymorphisms in rheumatoid arthritis in Taiwan, Hum Immunol 64 (2003), 366-373.
23. M.A. Gonzalez-Gay, J. Llorca, E. Sanchez, M.A. Lopez-Nevot, M.M. Amoli, C. Garcia-Porrua, W.E. Ollier and J. Martin, Inducible but not endothelial nitric oxide synthase polymorphism is associated with susceptibility to rheumatoid arthritis in northwest Spain, Rheumatology (Oxford) 43 (2004), 1182-1185.
24. M. Pascual, M.A. Lopez-Nevot, R. Caliz, B.P. Koeleman, A. Balsa, D. Pascual-Salcedo and J. Martin, Genetic determinants of rheumatoid arthritis: the inducible nitric oxide synthase (NOS2) gene promoter polymorphism, Genes Immun 3 (2002), 299-301.
25. A.G. Wilson, J.A. Symons, T.L. McDowell, H.O. McDevitt and G.W. Duff, Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation, Proc Natl Acad Sci U S A 94 (1997), 3195-3199.
26. K.M. Kroeger, K.S. Carville and L.J. Abraham, The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription, Mol Immunol 34 (1997), 391-399.
27. E. Louis, D. Franchimont, A. Piron, Y. Gevaert, N. Schaaf-Lafontaine, S. Roland, P. Mahieu, M. Malaise, D. De Groote, R. Louis and J. Belaiche, Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans, Clin Exp Immunol 113 (1998), 401-406.
28. B.M. Brinkman, D. Zuijdeest, E.L. Kaijzel, F.C. Breedveld and C.L.Verweij, Relevance of the tumor necrosis factor alpha (TNF alpha) -308 promoter polymorphism in TNF alpha gene regulation, J Inflamm 46 (1995), 32-41.
29. B.A. de Jong, R.G. Westendorp, A.M. Bakker and T.W. Huizinga, Polymorphisms in or near tumour necrosis factor (TNF)-gene do not determine levels of endotoxin-induced TNF production, Genes Immun 3 (2002), 25-29.
30. A.A. Rodriguez-Carreon, J. Zuniga, G. Hernandez-Pacheco, J.M. Rodriguez-Perez, N. Perez-Hernandez, J.V. Montes de Oca, M.H. Cardiel, J. Granados and G. Vargas-Alarcon, Tumor necrosis factor-alpha -308 promoter polymorphism contributes independently to HLA alleles in the severity of rheumatoid arthritis in Mexicans, J Autoimmun 24 (2005), 63-68.
31. D. Khanna, H. Wu, G. Park, V. Gersuk, R.H. Gold, G.T. Nepom, W.K. Wong, J.T. Sharp, E.F. Reed, H.E. Paulus and B.P. Tsao, Association of tumor necrosis factor alpha polymorphism, but not the shared epitope, with increased radiographic progression in a seropositive rheumatoid arthritis inception cohort, Arthritis Rheum 54 (2006), 1105-1116.
32. J.E. Fonseca, J. Cavaleiro, J. Teles, E. Sousa, V.L. Andreozzi, M. Antunes, M.A. Amaral-Turkman, H. Canhao, A.F. Mourao, J. Lopes, J. Caetano-Lopes, P.Weinmann, M. Sobral, P. Nero, M.J. Saavedra, A. Malcata, M. Cruz, R. Melo, A. Brana, L. Miranda, J.V. Patto, A. Barcelos, J.C. da Silva, L.M. Santos, G. Figueiredo, M. Rodrigues, H. Jesus, A. Quintal, T. Carvalho, J.A. da Silva, J. Branco and M.V. Queiroz, Contribution for new genetic markers of rheumatoid arthritis activity and severity: sequencing of the tumor necrosis factor-alpha gene promoter, Arthritis Res Ther 9 (2007), R37.
33. P. Nemec, M. Pavkova-Goldbergova, M. Stouracova, A. Vasku, M. Soucek and J. Gatterova, Polymorphism in the tumor necrosis factor-alpha gene promoter is associated with severity of rheumatoid arthritis in the Czech population, Clin Rheumatol 27 (2008), 59-65.
34. J.T. Cvetkovic, S. Wallberg-Jonsson, B. Stegmayr, S. Rantapaa-Dahlqvist and A.K. Lefvert, Susceptibility for and clinical manifestations of rheumatoid arthritis are associated with polymorphisms of the TNF-alpha, IL-1beta, and IL-1Ra genes, J Rheumatol 29 (2002), 212-219.
35. H. Marotte, P. Farge, P. Gaudin, C. Alexandre, B. Mougin and P. Miossec, The association between periodontal disease and joint destruction in rheumatoid arthritis extends the link between the HLA-DR shared epitope and severity of bone destruction, Ann Rheum Dis 65 (2006), 905-909.
36. A.G.Wilson, N. de Vries, L.B. van de Putte and G.W. Duff, A tumour necrosis factor alpha polymorphism is not associated with rheumatoid arthritis, Ann Rheum Dis 54 (1995), 601-603.
37. A. Pawlik, M. Florczak, L. Ostanek, M. Brzosko, I. Brzosko and B.G. Szklarz, TNF-alpha -308 promoter polymorphism in patients with rheumatoid arthritis, Scand J Rheumatol 34 (2005), 22-26.
38. J.M. Grossman and E. Brahn, Rheumatoid arthritis: current clinical and research directions, J Womens Health 6 (1997), 627-638.
39. B. Vidan-Jeras, B. Jurca, V. Dolzan, M. Jeras, K. Breskvar and M. Bohinjec, Caucasian Slovenian normal, in: HLA 1998, D. Gjertson and P. Terasaki eds, American society for histocompatibility and immunogenetics, Lenexa, 1998, pp. 180-181.